Comparison of the protective effects of selective endothelin-a receptor antagonist, ambrisentan, and dual endothelin-A/B receptor antagonist, bosentan, in experimental renal ischemia reperfusion injury.
Bratisl Lek Listy. 2020;121(8):547-553. doi: 10.4149/BLL_2020_091.
Bratisl Lek Listy. 2020.
PMID: 32726116